Balyasny Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-259,413
| Closed | -$1.34M | – | 1942 |
|
|
2021
Q3 | $1.34M | Buy |
+259,413
| New | +$1.34M | 0.01% | 1049 |
|
|
2019
Q1 | – | Sell |
-567,401
| Closed | -$3.26M | – | 1267 |
|
|
2018
Q4 | $3.26M | Sell |
567,401
-414,599
| -42% | -$2.38M | 0.02% | 521 |
|
|
2018
Q3 | $13.3M | Buy |
982,000
+165,716
| +20% | +$2.25M | 0.06% | 342 |
|
|
2018
Q2 | $9.69M | Sell |
816,284
-130,784
| -14% | -$1.55M | 0.04% | 420 |
|
|
2018
Q1 | $10.6M | Buy |
947,068
+224,078
| +31% | +$2.52M | 0.04% | 433 |
|
|
2017
Q4 | $4.83M | Buy |
722,990
+123,190
| +21% | +$823K | 0.02% | 717 |
|
|
2017
Q3 | $4.91M | Buy |
599,800
+411,313
| +218% | +$3.37M | 0.02% | 606 |
|
|
2017
Q2 | $846K | Buy |
+188,487
| New | +$846K | ﹤0.01% | 957 |
|